Safety and efficacy of AMG 714 in patients with type 2 refractory coeliac disease: a phase 2a, randomised, double-blind, placebo-controlled, parallel-group study

  1. Cellier, C.
  2. Bouma, G.
  3. van Gils, T.
  4. Khater, S.
  5. Malamut, G.
  6. Crespo, L.
  7. Collin, P.
  8. Green, P.H.R.
  9. Crowe, S.E.
  10. Tsuji, W.
  11. Butz, E.
  12. Cerf-Bensussan, N.
  13. Macintyre, E.
  14. Parnes, J.R.
  15. Leon, F.
  16. Hermine, O.
  17. Mulder, C.J.
  18. Jabri, B.
  19. Murray, J.
  20. DiMarino, A.
  21. Kelly, C.P.
  22. Byrnes, V.
  23. Sanders, D.
  24. Lundin, K.E.
  25. Schumann, M.
  26. Bontkes, H.
  27. Meresse, B.
  28. Roy Ariño, G.
  29. Bhagat, G.
  30. Viiri, K.
  31. Rounioja, S.
  32. Bui, J.
  33. Perez Maseda, R.
  34. García-Hoz, C.
  35. Trinquand, A.
  36. Vlad, G.
  37. Hadjivassiliou, M.
  38. Azizi, M.
  39. Blanchard, A.
  40. Llewellyn, B.
  41. Palmer, A.
  42. Raymond, R.
  43. Show all authors +
Journal:
The Lancet Gastroenterology and Hepatology

ISSN: 2468-1253

Year of publication: 2019

Volume: 4

Issue: 12

Pages: 960-970

Type: Article

DOI: 10.1016/S2468-1253(19)30265-1 GOOGLE SCHOLAR lock_openOpen access editor